Portfolio Design Labs LLC Purchases Shares of 5,442 Ventas, Inc. $VTR

Portfolio Design Labs LLC purchased a new stake in Ventas, Inc. (NYSE:VTR) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 5,442 shares of the real estate investment trust’s stock, valued at approximately $483,000.

A number of other institutional investors have also made changes to their positions in the business. PCM Encore LLC acquired a new position in shares of Ventas during the 2nd quarter worth about $482,000. Vise Technologies Inc. acquired a new stake in Ventas in the 2nd quarter valued at approximately $550,000. OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of Ventas during the second quarter worth approximately $2,357,000. one8zero8 LLC acquired a new position in shares of Ventas during the second quarter worth approximately $3,379,000. Finally, NewEdge Wealth LLC bought a new stake in shares of Ventas in the second quarter valued at approximately $3,113,000. 94.18% of the stock is currently owned by institutional investors.

Ventas Stock Up 1.1%

NYSE VTR opened at $92.82 on Friday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock’s 50 day moving average is $91.18 and its two-hundred day moving average is $87.04. The company has a market capitalization of $47.61 billion, a price-to-earnings ratio of 171.89, a PEG ratio of 2.12 and a beta of 0.69. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60.

Ventas (NYSE:VTR) last released its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the company posted $0.87 EPS. The company’s revenue was up 21.7% compared to the same quarter last year. Equities analysts forecast that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on VTR shares. BMO Capital Markets boosted their target price on shares of Ventas from $105.00 to $107.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. JPMorgan Chase & Co. lifted their price objective on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Citigroup upped their target price on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. Finally, Wells Fargo & Company raised their target price on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.